SLC16A1 and cancer: Between clinicopathological factors and MCTs, a moderate correlation was observed only between density of MCT1 in cancer cells and histology (r = 0.484, P<0.001) with high expression in 58% of squamous cell carcinoma compared to 34% in adenocarcinoma.